Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sutro Biopharma (STRO) Return on Capital Employed (2018 - 2025)

Sutro Biopharma (STRO) has disclosed Return on Capital Employed for 8 consecutive years, with 0.34% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed rose 48.0% to 0.34% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.34% through Dec 2025, up 48.0% year-over-year, with the annual reading at 0.2% for FY2025, 61.0% up from the prior year.
  • Return on Capital Employed hit 0.34% in Q4 2025 for Sutro Biopharma, up from 1.13% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.19% in Q2 2021 to a low of 1.13% in Q1 2025.
  • Historically, Return on Capital Employed has averaged 0.48% across 5 years, with a median of 0.38% in 2022.
  • Biggest YoY gain for Return on Capital Employed was 48bps in 2025; the steepest drop was -84bps in 2025.
  • Year by year, Return on Capital Employed stood at 0.31% in 2021, then decreased by -22bps to 0.38% in 2022, then soared by 35bps to 0.25% in 2023, then tumbled by -232bps to 0.83% in 2024, then surged by 58bps to 0.34% in 2025.
  • Business Quant data shows Return on Capital Employed for STRO at 0.34% in Q4 2025, 1.13% in Q3 2025, and 0.94% in Q2 2025.